本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

MEDLAB CLINICAL LTD

6.600
0.000
成交量:- -
成交額:- -
市值:1,507.11萬
市盈率:-7.07
高:6.600
開:6.600
低:6.600
收:6.600
資料載入中...

公司資料

公司名字:
MEDLAB CLINICAL LTD
交易所:
ASX
成立時間:
- -
員工人數:
- -
公司地址:
- -
郵編:
- -
電話:
- -
傳真:
- -
簡介:
Medlab Clinical Limited engages in the sale of nutraceutical products, and pharmaceutical research and commercialization in Australia. The company develops bio-therapeutics for bio-therapeutics for chronic kidney diseases, pre-diabetes/obesity, depression, and musculoskeletal muscle loss associated with ageing. It also provides nutraceuticals for anti-inflammatory, cardiovascular support, endocrine support, gastrointestinal support, immunological support, infants and toddlers, metabolic support, musculoskeletal support, neurological support, sports performance, urogenital support, and weight management, as well as for men, pregnancy, seniors, teenagers, and women support. Medlab Clinical Limited was founded in 2012 and is based in Alexandria, Australia.